PNT logo

POINT Biopharma Global (PNT) Free Cash Flow

Annual FCF

$170.75 M
+$224.25 M+419.16%

December 31, 2022

Summary

Performance

1-Year Change

+419.16%

3-Year Change

+1043.37%

5-Year Change

+1043.37%

15-Year Change

+1043.37%

PNT Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$170.75 M
PNT annual free cash flow is currently at an all-time high

3-Year Low

-$53.50 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
PNT previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
PNT next annual earnings announcement has not yet been scheduled

OtherPNTcash flowmetrics:

Annual CFO

$183.52 M
PNT annual cash flow from operations is $183.52 million

Annual CFF

$130.36 M
PNT annual cash flow from financing activities is $130.36 million

Annual CFI

-$266.26 M
PNT annual cash flow from investing activities is -$266.26 million

Annual CAPEX

$12.77 M
PNT annual capital expenditures is $12.77 million

Quarterly FCF

-$34.53 M
+$47.14 M+57.72%

September 30, 2023

Summary

Performance

3-Month Change

+57.72%

1-Year Change

-15.3%

3-Year Change

-

5-Year Change

-

PNT Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$234.85 M
PNT quarterly free cash flow is currently -114.70% below its historical high of $234.85 million

3-Year Low

-$81.67 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
PNT previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
PNT next earnings announcement has not yet been scheduled

OtherPNTcash flowmetrics:

Quarterly CFO

-$28.13 M
PNT quarterly cash flow from operations is -$28.13 million

Quarterly CFF

-$152.30 K
PNT quarterly cash flow from financing activities is -$152.30 thousand

Quarterly CFI

-$7.40 M
PNT quarterly cash flow from investing activities is -$7.40 million

Quarterly CAPEX

$6.39 M
PNT quarterly capital expenditures is $6.39 million

TTM FCF

$92.74 M
-$4.58 M-4.71%

September 30, 2023

Summary

Performance

3-Month Change

-4.71%

1-Year Change

+218.74%

3-Year Change

-

5-Year Change

-

PNT TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$170.75 M
PNT TTM free cash flow is currently -45.69% below its historical high of $170.75 million

3-Year Low

-$78.10 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
PNT previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
PNT next earnings announcement has not yet been scheduled

OtherPNTcash flowmetrics:

TTM CFO

$112.06 M
PNT TTM cash flow from operations is $112.06 million

TTM CFF

$13.50 M
PNT TTM cash flow from financing activities is $13.50 million

TTM CFI

-$229.73 M
PNT TTM cash flow from investing activities is -$229.73 million

TTM CAPEX

$19.32 M
PNT TTM capital expenditures is $19.32 million

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

$170.75 M
PNT annual free cash flow is $170.75 million

Annual CFO

$183.52 M
PNT annual cash flow from operations is $183.52 million

Annual CAPEX

$12.77 M
PNT annual capital expenditures is $12.77 million

PNT Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+419.2%-15.3%+218.7%
3 y3 years+1043.4%--
5 y5 years+1043.4%--

PNT Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-131.3%-114.7%+136.5%-45.7%-184.2%
5 y5-yearat high-131.3%-114.7%+136.5%-45.7%-184.2%
alltimeall timeat high-131.3%-114.7%+136.5%-45.7%-184.2%

POINT Biopharma Global Free Cash Flow History

DateAnnualQuarterlyTTM
Sep 2023
-
-$34.53 M(-57.7%)
$92.74 M(-4.7%)
Jun 2023
-
-$81.67 M(+215.1%)
$97.32 M(-37.7%)
Mar 2023
-
-$25.92 M(-111.0%)
$156.27 M(-8.5%)
Dec 2022
$170.75 M
$234.85 M(-884.3%)
$170.75 M(-318.6%)
Sep 2022
-
-$29.94 M(+31.8%)
-$78.10 M(+20.2%)
Jun 2022
-
-$22.72 M(+98.7%)
-$64.96 M(+20.8%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$11.43 M(-18.4%)
-$53.78 M(+0.5%)
Dec 2021
-$53.50 M(+195.6%)
-$14.01 M(-16.6%)
-$53.50 M(+35.5%)
Sep 2021
-
-$16.80 M(+45.7%)
-$39.49 M(+74.1%)
Jun 2021
-
-$11.53 M(+3.4%)
-$22.69 M(+103.4%)
Mar 2021
-
-$11.15 M
-$11.15 M
Dec 2020
-$18.10 M
-
-

FAQ

  • What is POINT Biopharma Global annual free cash flow?
  • What is the all time high annual FCF for POINT Biopharma Global?
  • What is POINT Biopharma Global annual FCF year-on-year change?
  • What is POINT Biopharma Global quarterly free cash flow?
  • What is the all time high quarterly FCF for POINT Biopharma Global?
  • What is POINT Biopharma Global quarterly FCF year-on-year change?
  • What is POINT Biopharma Global TTM free cash flow?
  • What is the all time high TTM FCF for POINT Biopharma Global?
  • What is POINT Biopharma Global TTM FCF year-on-year change?

What is POINT Biopharma Global annual free cash flow?

The current annual FCF of PNT is $170.75 M

What is the all time high annual FCF for POINT Biopharma Global?

POINT Biopharma Global all-time high annual free cash flow is $170.75 M

What is POINT Biopharma Global annual FCF year-on-year change?

Over the past year, PNT annual free cash flow has changed by +$224.25 M (+419.16%)

What is POINT Biopharma Global quarterly free cash flow?

The current quarterly FCF of PNT is -$34.53 M

What is the all time high quarterly FCF for POINT Biopharma Global?

POINT Biopharma Global all-time high quarterly free cash flow is $234.85 M

What is POINT Biopharma Global quarterly FCF year-on-year change?

Over the past year, PNT quarterly free cash flow has changed by -$4.58 M (-15.30%)

What is POINT Biopharma Global TTM free cash flow?

The current TTM FCF of PNT is $92.74 M

What is the all time high TTM FCF for POINT Biopharma Global?

POINT Biopharma Global all-time high TTM free cash flow is $170.75 M

What is POINT Biopharma Global TTM FCF year-on-year change?

Over the past year, PNT TTM free cash flow has changed by +$170.84 M (+218.74%)